Shubhi Pandey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shubhi Pandey has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Arun Kumar Shukla
Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India
2 shared publications Tomasz Maciej Stepniewski
Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences of Pompeu Fabra University (UPF)-Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
2 shared publications- Ashish Srivastava
Siddarth University
1 shared publication Asuka Inoue
Graduate School of Pharmaceutical Sciences Tohoku University Sendai Japan
1 shared publication- Aylin Carla Hanyaloglu
Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
1 shared publication Boskey Patel
Saint Vincent Hospital, Worcester, MA, USA
1 shared publication
Latest Publications
- Open Access
- 9 May 2021
- Published by CAB PUBLISHER in International Journal of Medical and Biomedical Studies
- Vol. 5 (5)
A RETROSPECTIVE STUDY OF ROLE OF SERUM FERRITIN AS A PROGNOSTIC MARKER IN COVID-19 PATIENTS, IN A TERTIARY CARE CENTRE IN INDORE DISTRICT, STATE M.P.
Background: Ferritin is a key mediator of immune dysregulation, especially under extreme hyperferritinemia, via direct immune-suppressive and pro-inflammatory effects, contributing to the cytokine storm. In several studies, it was found that individuals with severe and very severe COVID-19 exhibited increased serum ferritin level, being serum ferritin in the very severe COVID-19 group significantly higher than in the severe COVID-19 group Method: All patients had a positive polymerase chain reaction (PCR) test results. Patients with the history of comorbidities such as Hypertension (HTN), Diabetes Mellitus (DM), Chronic obstructive pulmonary disease (COPD), Asthama, Heart failure, Chronic renal Failure (CRF) were included. The clinical and laboratory findings including haemoglobin, wbc counts, differential counts, liver function tests, c-reactive protein (CRP), ferritin and interleukin -6 (IL-6) were obtained from the database. Results: A total of 38 patients were included in the study. The median age of study population was 52.5 years (13-90) and 65% of patients were male. Patients in the severe group were significantly older and had a higher frequency of hypertension, diabetes mellitus, coronary heart disease, heart failure and chronic renal failure as compared to the patients with the mild group. In addition frequency of dyspnea was higher in the severe group. It was observed that the serum ferritin levels of those patients who fell in the serious category were found significantly raised. P value for Serum Ferritin and Category (serious/mild) is 0.048 which is less than < 0.05. Conclusion: Hence it was concluded that there was a strong association between increased serum ferritin levels and the severity of the disease. Early analysis of ferritin levels in patients with covid 19 might effectively define the severity of disease. Keywords: Serum, Ferritin, Covid & Marker.
- 9 May 2021
- Published by CAB PUBLISHER in International Journal of Medical and Biomedical Studies
- Vol. 5 (5)
Open AccessA RETROSPECTIVE STUDY OF ROLE OF SERUM FERRITIN AS A PROGNOSTIC MARKER IN COVID-19 PATIENTS, IN A TERTIARY CARE CENTRE IN INDORE DISTRICT, STATE M.P.
Background: Ferritin is a key mediator of immune dysregulation, especially under extreme hyperferritinemia, via direct immune-suppressive and pro-inflammatory effects, contributing to the cytokine storm. In several studies, it was found that individuals with severe and very severe COVID-19 exhibited increased serum ferritin level, being serum ferritin in the very severe COVID-19 group significantly higher than in the severe COVID-19 group Method: All patients had a positive polymerase chain reaction (PCR) test results. Patients with the history of comorbidities such as Hypertension (HTN), Diabetes Mellitus (DM), Chronic obstructive pulmonary disease (COPD), Asthama, Heart failure, Chronic renal Failure (CRF) were included. The clinical and laboratory findings including haemoglobin, wbc counts, differential counts, liver function tests, c-reactive protein (CRP), ferritin and interleukin -6 (IL-6) were obtained from the database. Results: A total of 38 patients were included in the study. The median age of study population was 52.5 years (13-90) and 65% of patients were male. Patients in the severe group were significantly older and had a higher frequency of hypertension, diabetes mellitus, coronary heart disease, heart failure and chronic renal failure as compared to the patients with the mild group. In addition frequency of dyspnea was higher in the severe group. It was observed that the serum ferritin levels of those patients who fell in the serious category were found significantly raised. P value for Serum Ferritin and Category (serious/mild) is 0.048 which is less than < 0.05. Conclusion: Hence it was concluded that there was a strong association between increased serum ferritin levels and the severity of the disease. Early analysis of ferritin levels in patients with covid 19 might effectively define the severity of disease. Keywords: Serum, Ferritin, Covid & Marker.
- Open Access
- 11 September 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (37) , eabb8368
Distinct phosphorylation sites in a prototypical GPCR differently orchestrate β-arrestin interaction, trafficking, and signaling
Agonist-induced phosphorylation of G protein–coupled receptors (GPCRs) is a key determinant for their interaction with β-arrestins (βarrs) and subsequent functional responses. Therefore, it is important to decipher the contribution and interplay of different receptor phosphorylation sites in governing βarr interaction and functional outcomes. Here, we find that several phosphorylation sites in the human vasopressin receptor (V2R), positioned either individually or in clusters, differentially contribute to βarr recruitment, trafficking, and ERK1/2 activation. Even a single phosphorylation site in V2R, suitably positioned to cross-talk with a key residue in βarrs, has a decisive contribution in βarr recruitment, and its mutation results in strong G-protein bias. Molecular dynamics simulation provides mechanistic insights into the pivotal role of this key phosphorylation site in governing the stability of βarr interaction and regulating the interdomain rotation in βarrs. Our findings uncover important structural aspects to better understand the framework of GPCR-βarr interaction and biased signaling.
- 11 September 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (37) , eabb8368
Open AccessDistinct phosphorylation sites in a prototypical GPCR differently orchestrate β-arrestin interaction, trafficking, and signaling
Agonist-induced phosphorylation of G protein–coupled receptors (GPCRs) is a key determinant for their interaction with β-arrestins (βarrs) and subsequent functional responses. Therefore, it is important to decipher the contribution and interplay of different receptor phosphorylation sites in governing βarr interaction and functional outcomes. Here, we find that several phosphorylation sites in the human vasopressin receptor (V2R), positioned either individually or in clusters, differentially contribute to βarr recruitment, trafficking, and ERK1/2 activation. Even a single phosphorylation site in V2R, suitably positioned to cross-talk with a key residue in βarrs, has a decisive contribution in βarr recruitment, and its mutation results in strong G-protein bias. Molecular dynamics simulation provides mechanistic insights into the pivotal role of this key phosphorylation site in governing the stability of βarr interaction and regulating the interdomain rotation in βarrs. Our findings uncover important structural aspects to better understand the framework of GPCR-βarr interaction and biased signaling.
- Open Access
- 26 July 2020
- Published by Springer Nature in EMBO Reports
- Vol. 21 (9) , e49886
Key phosphorylation sites in GPCRs orchestrate the contribution of β‐Arrestin 1 in ERK1/2 activation
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 26 July 2020
- Published by Springer Nature in EMBO Reports
- Vol. 21 (9) , e49886
Open AccessKey phosphorylation sites in GPCRs orchestrate the contribution of β‐Arrestin 1 in ERK1/2 activation
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.